The FDA approved linaclotide (Linzess) capsules to treat irritable bowel syndrome with constipation (IBS-C) in children age 7 ...

The first botulinum toxin product, onabotulinumtoxinA, was approved by the FDA in 1989. Since then, FDA has approved several ...

The Food and Drug Administration has issued 18 warning letters to online retailers selling unapproved and misbranded Botox ...

U.S. health regulators on Wednesday sent warning letters to 18 websites selling counterfeit or unapproved versions of Botox and similar injectable drugs commonly used to ...

In contrast, the experts noted that several recent FDA approvals introduced first-in-class therapies to the oncology landscape. 1 Among these are menin inhibitors, which block the interaction between ...

Mike Schaefer was given a diagnosis of a rare type of metastatic leiomyosarcoma. His tumors spread throughout his body, including his liver. He said he was given three to five months to live. This was ...

Biohaven stock cratered Wednesday after the FDA rejected the company's treatment for an inherited neurodegenerative disease.

Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy, ...

IMCIVREE now publicly covered for weight management due to Bardet-Biedl syndrome (BBS) in Ontario, Alberta, British Columbia, Saskatchewan, Nova Scotia and under NIHB ...

StemCyte International (TPEX: 4178), a global leader in cord blood banking and cell therapy, today announced the launch of its Public Bank Matching Protection Service in Taiwan, developed in ...

CELEBRATION, Fla., Nov. 05, 2025 (GLOBE NEWSWIRE) -- Zevra Therapeutics, Inc. (NasdaqGS: ZVRA) (Zevra, or the Company), a commercial-stage company focused on providing therapies for people living with ...